Inflammation Archives - Purablis-Medicinal Tinctures with CBD, THCA and THC

Inflammation Marijuana Studies and

Inflammation Cannabis Research

09/28/2018

Author(s): Thomas W. Klein.

Drugs derived from cannabis have immunosuppressive and anti-inflammatory properties, and may have great therapeutic utility in chronic diseases. View study

09/28/2018

Author(s): C Benito, RM Tolo´n, MR Pazos, E Nu´n˜ez, AI Castillo, and J Romero.

The anti-inflammatory effects triggered by the activation of CB2 receptor make it an attractive target for the development of new anti-inflammatory therapies. In any case, more research is needed to corroborate the potential utility of cannabinoid-based treatments devoid of unwanted psychoactive effects. View study

09/28/2018

Author(s): .

This study demonstrates that dimethylheptyl-cannabidiol (DMH-CBD) has anti-inflammatory and antiproliferative properties similar to cannabidiol (CBD). DMH-CBD acts by negatively regulating the expression of inflammatory cytokines and protecting microglial cells by inducing an adaptive cellular response against inflammatory stimuli and oxidative lesions. View study

09/28/2018

Author(s): A Alhamoruni1, KL Wright2, M Larvin1 and SE O’Sullivan1.

Cannabinoids can modulate intestinal permeability in an in vitro model of inflammation. This study suggests that cannabis-based drugs may be of therapeutic benefit in the treatment of inflammatory bowel disorders associated with abnormal intestinal permeability. View study

09/28/2018

Author(s): Wei Xiong,1 Tanxing Cui,3,4,5 Kejun Cheng,2 Fei Yang,6 Shao-Rui Chen,7 Dan Willenbring,3,4,5 Yun Guan,6 Hui-Lin Pan,7 Ke Ren,8 Yan Xu,3,4,5 and Li Zhang1.

Chronic pain produced by diseases that involve the dysfunction of glycine receptors (GlyR) can be alleviated and treated by cannabinoids, which are evidenced as therapeutic agents. View study

09/28/2018

Author(s): M. Mecha, A. Feliú, P.M. Iñigo, L. Mestre, F.J. Carrillo-Salinas, C. Guaza.

This study results highlight the anti-inflammatory effects of cannabidiol in this viral model of multiple sclerosis and demonstrate the significant therapeutic potential of this compound for the treatment of pathologies with an inflammatory component. View study

09/28/2018

Author(s): Kun Li, Jia-yan Feng, Yong-yu Li, Birol Yuece, Xu-hong Lin, Liang-ying Yu, Yan-na Li,Ya-jing Feng, and Martin Storr.

The treatment with cannabidiol or O-1602 significantly improved the pathological changes of mice with experimental acute pancreatitis, showing anti-inflammatory effects. View study
Inflammation in the CNS (1)inflammation-in-the-cns…